Richard J Chenery is a notable inventor based in Hitchin, GB. He has made significant contributions to the field of molecular biology, particularly in the study of rat mdr1b2 polypeptides and polynucleotides. With a total of 2 patents, his work has implications for understanding drug resistance and screening for potential therapeutic compounds.

Latest Patents

Chenery's latest patents focus on polynucleotide and polypeptide sequences encoding rat mdr1b2. These patents disclose methods for producing rat mdr1b2 polypeptides through recombinant techniques. Additionally, they outline methods for screening compounds that either agonize or antagonize rat mdr1b2. Furthermore, his patents describe a selection screen method to discover compounds that neither agonize nor antagonize rat mdr1b2, showcasing his innovative approach to molecular screening.

Career Highlights

Throughout his career, Richard J Chenery has worked with prominent organizations, including SmithKline Beecham Corporation. His experience in these companies has allowed him to develop and refine his expertise in molecular biology and patentable innovations.

Collaborations

Chenery has collaborated with notable colleagues, including Kimberly Anne Brun and Harma Ellens. These partnerships have likely contributed to his success in the field and the development of his patented technologies.

Conclusion

Richard J Chenery's contributions to molecular biology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence research and development in understanding drug resistance mechanisms.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com